Paediatric (6-17 years) research study in episodic migraine

Recruiting 6–17 year olds with episodic migraine

What is the purpose of the study?

Amgen is currently running a migraine paediatric study in the UK. It is currently recruiting 6–17 year olds with episodic migraine.

If you choose to participate, and if the study is right for you, you will be in this study for about five months where you will receive either investigational medicine or placebo.

Following this, there will be an optional 40-week extension phase during which all patients will receive the investigational medicine.

Who can take part?

6–17 year olds with episodic migraine

What will the study involve?

The patient will be in this study for about five months where they will receive either investigational medicine or placebo.

Following this, there will be an optional 40-week extension phase during which all patients will receive the investigational medicine.

How to take part

If you would like to take part in this trial, please contact one of the below centres depending on your location.

  • Great Ormond Street Hospital for Children, London under Dr Prab Prabhakar (A referral from an NHS paediatrician is needed for referral to this site)
  • Royal Hospital for Children, Glasgow under Dr Ishaq Abu Arafeh
  • Evelina Childrens Hospital, London under Dr Ming Lim
  •  4MCS Manchester: Suite A, Beech Court, M60 Office Park, Wynne Ave, Swinton, Clifton, Manchester M27 8FF

Added: 11 November 2024 | Deadline to sign up: 12 February 2026